Subscribe to Newsletter

Analytical Science

Discovery & Development Analytical Science

Talking Extractables & Leachables testing using Orbitrap based mass spectrometry

Hear from Kate Comstock as she talks about her long experience with extractables testing in pharmaceutical companies

Discovery & Development Analytical Science

Talking Extractables & Leachables with Glaxo Smith Kline

Hear from industry expert Jason Creasey as he discusses the history of extractable and leachable testing

Discovery & Development Analytical Science

Talking Extractables & Leachables with Smithers Rapra

Hear how new developments in analytical technology are providing additional insights into unknown contaminants

Discovery & Development Analytical Science

Solving the challenges of Leachable pharmaceutical impurities using a full analytical portfolio

Extractables and leachable compounds are a complex and ever growing list of pharmaceutical impurities

Discovery & Development Analytical Science

Biopharmaceutical characterization demands advanced detection capabilities

Innovation that takes technology design to the physical limits

Discovery & Development Analytical Science

Biotherapeutic Protein Characterization Challenges: The NIBRT Perspective

NIBRT Principle Investigator Jonathan Bones discusses the challenges involved in biotherapeutic protein characterization.

Discovery & Development Analytical Science

Biopharmaceuticals are complex; analyzing them just got a lot easier

Great technology takes complex challenges and provides simple, robust solutions.

Discovery & Development Analytical Science

The Search for the Ideal Detector

| Dorina Kotoni

Will aerosol-based detectors ever meet all the needs of the pharmaceutical industry?

Discovery & Development Analytical Science

Affliction Prediction

| James Strachan

Could drug development be guided by a new algorithm that predicts the side effects of potential medicines?

Discovery & Development Business Practice

Morphologically-Directed Raman Spectroscopy used for the characterization of protein aggregates in suspension

This application note explores the use of the Morphologi G3-ID for Morphologically-Directed Raman spectroscopy (MDRS) to identify and analyze contaminants including protein aggregates present in a stressed sample of lysozyme, and to compare particles held in suspension within a thin path wet cell with those collected on a filter membrane.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register